Ceribell, Stock Today
| CBLL Stock | 21.03 0.37 1.73% |
PerformanceVery Weak
| Odds Of DistressLow
|
CeriBell, is selling for 21.03 as of the 16th of March 2025. This is a 1.73 percent decrease since the beginning of the trading day. The stock's lowest day price was 21.03. CeriBell, has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Moving against CeriBell, Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CeriBell, Stock Highlights
| President CoFounder | Xingjuan Chao |
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, NASDAQ Composite, NASDAQ Health Care, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
CeriBell, (CBLL) is traded on NASDAQ Exchange in USA. It is located in 360 North Pastoria Avenue, Sunnyvale, CA, United States, 94085 and employs 281 people. CeriBell, is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 768.07 M. CeriBell, conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 35.82 M outstanding shares of which 831.8 K shares are currently shorted by private and institutional investors with about 4.15 trading days to cover.
CeriBell, generates negative cash flow from operations
Check CeriBell, Probability Of Bankruptcy
Ownership AllocationCeriBell, holds a total of 35.82 Million outstanding shares. The majority of CeriBell, outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CeriBell, to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CeriBell,. Please pay attention to any change in the institutional holdings of CeriBell, as this could imply that something significant has changed or is about to change at the company. Also note that nearly one million six thousand six hundred sixty invesors are currently shorting CeriBell, expressing very little confidence in its future performance.
Check CeriBell, Ownership Details
CeriBell, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. CeriBell, market risk premium is the additional return an investor will receive from holding CeriBell, long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.43) | |||
| Treynor Ratio | (2.71) | |||
| Mean Deviation | 2.63 |
CeriBell, Stock Against Markets
CeriBell, Corporate Management
| David Foehr | Finance VP | Profile | |
| Sean Manni | Senior Sales | Profile | |
| Baharan Kamousi | Senior Science | Profile | |
| Dan Rogy | Senior Operations | Profile | |
| Kristie Rodenbush | Chief Officer | Profile | |
| Joshua Copp | Chief Officer | Profile | |
| MBA JD | General Counsel | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CeriBell,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.